智通财经APP获悉，长江生命科技(00775)再跌超4%，月内累计跌幅近15%。截至发稿，跌4%，报0.72港元，成交额592.62万港元。
消息面上，长江生命科技发布年度业绩，该集团取得收入54.1亿港元，同比减少2%；公司股东权益应占亏损1.87亿港元，同比增加47.61%。公告称，2025年度的股东应占亏损较2024年度增加6020万港元，当中反映研发开支增加6650万港元，以及数项非现金的特殊项目及一次性项目。
智通财经APP获悉，长江生命科技(00775)再跌超4%，月内累计跌幅近15%。截至发稿，跌4%，报0.72港元，成交额592.62万港元。
消息面上，长江生命科技发布年度业绩，该集团取得收入54.1亿港元，同比减少2%；公司股东权益应占亏损1.87亿港元，同比增加47.61%。公告称，2025年度的股东应占亏损较2024年度增加6020万港元，当中反映研发开支增加6650万港元，以及数项非现金的特殊项目及一次性项目。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.